Koshinski Asset Management Inc. Has $301,000 Stock Holdings in Danaher Co. (NYSE:DHR)

Koshinski Asset Management Inc. lifted its holdings in shares of Danaher Co. (NYSE:DHR) by 16.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,300 shares of the conglomerate’s stock after buying an additional 182 shares during the period. Koshinski Asset Management Inc.’s holdings in Danaher were worth $301,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the business. Wellington Management Group LLP raised its holdings in shares of Danaher by 18.6% in the 3rd quarter. Wellington Management Group LLP now owns 24,930,281 shares of the conglomerate’s stock valued at $6,185,203,000 after purchasing an additional 3,905,449 shares during the period. Moneta Group Investment Advisors LLC raised its holdings in shares of Danaher by 96,490.5% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 23,287,013 shares of the conglomerate’s stock valued at $6,180,839,000 after purchasing an additional 23,262,904 shares during the period. Bank of New York Mellon Corp raised its holdings in Danaher by 6.5% in the 3rd quarter. Bank of New York Mellon Corp now owns 8,183,501 shares of the conglomerate’s stock valued at $2,030,327,000 after acquiring an additional 502,868 shares during the period. Northern Trust Corp raised its holdings in Danaher by 1.7% in the 3rd quarter. Northern Trust Corp now owns 8,100,722 shares of the conglomerate’s stock valued at $2,009,789,000 after acquiring an additional 134,905 shares during the period. Finally, Norges Bank bought a new position in Danaher in the 4th quarter valued at about $2,057,164,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Danaher news, SVP Georgeann Couchara sold 2,622 shares of Danaher stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $242.67, for a total transaction of $636,280.74. Following the transaction, the senior vice president now directly owns 4,244 shares of the company’s stock, valued at approximately $1,029,891.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Teri List sold 3,289 shares of Danaher stock in a transaction dated Tuesday, February 6th. The stock was sold at an average price of $248.32, for a total value of $816,724.48. Following the completion of the transaction, the director now directly owns 19,726 shares of the company’s stock, valued at approximately $4,898,360.32. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Georgeann Couchara sold 2,622 shares of Danaher stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $242.67, for a total value of $636,280.74. Following the completion of the transaction, the senior vice president now directly owns 4,244 shares of the company’s stock, valued at $1,029,891.48. The disclosure for this sale can be found here. In the last three months, insiders have sold 32,957 shares of company stock valued at $8,265,802. 11.10% of the stock is currently owned by company insiders.

Analyst Ratings Changes

DHR has been the topic of several research analyst reports. JPMorgan Chase & Co. increased their price target on shares of Danaher from $250.00 to $270.00 and gave the company an “overweight” rating in a report on Wednesday, December 20th. Royal Bank of Canada raised their target price on shares of Danaher from $254.00 to $282.00 and gave the stock an “outperform” rating in a report on Wednesday, January 31st. KeyCorp raised their target price on shares of Danaher from $260.00 to $290.00 and gave the stock an “overweight” rating in a report on Thursday, February 1st. HSBC started coverage on shares of Danaher in a report on Monday, December 18th. They set a “hold” rating on the stock. Finally, Barclays increased their price target on shares of Danaher from $240.00 to $260.00 and gave the stock an “equal weight” rating in a research report on Wednesday, April 10th. Seven analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, Danaher has an average rating of “Moderate Buy” and a consensus target price of $267.43.

Danaher Stock Performance

Shares of Danaher stock opened at $239.66 on Tuesday. Danaher Co. has a fifty-two week low of $182.09 and a fifty-two week high of $259.00. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.68 and a quick ratio of 1.37. The firm has a market capitalization of $177.48 billion, a P/E ratio of 37.51, a P/E/G ratio of 3.65 and a beta of 0.83. The company’s 50 day moving average price is $249.58 and its two-hundred day moving average price is $229.84.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, January 30th. The conglomerate reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.91 by $0.18. The business had revenue of $6.41 billion during the quarter, compared to analyst estimates of $6.10 billion. Danaher had a return on equity of 12.25% and a net margin of 17.26%. Danaher’s revenue for the quarter was down 10.2% compared to the same quarter last year. During the same period last year, the company earned $2.87 EPS. On average, equities analysts forecast that Danaher Co. will post 7.62 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Thursday, March 28th will be issued a dividend of $0.27 per share. The ex-dividend date is Wednesday, March 27th. This is an increase from Danaher’s previous quarterly dividend of $0.24. This represents a $1.08 annualized dividend and a yield of 0.45%. Danaher’s payout ratio is presently 16.90%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.